We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Walking Aids in the Management of Hip Osteoarthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00506714
Recruitment Status : Completed
First Posted : July 25, 2007
Results First Posted : September 28, 2012
Last Update Posted : October 4, 2012
Sponsor:
Information provided by (Responsible Party):

Study Type: Interventional
Study Design: Allocation: Non-Randomized;   Intervention Model: Parallel Assignment;   Masking: None (Open Label);   Primary Purpose: Treatment
Condition: Osteoarthritis
Intervention: Device: single point cane

  Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Group 1 Healthy adults
Group 2 Adults with symptomatic hip osteoarthritis

Participant Flow:   Overall Study
    Group 1   Group 2
STARTED   13   13 
COMPLETED   13   13 
NOT COMPLETED   0   0 



  Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Group 1 Healthy adults
Group 2 Adults with symptomatic hip osteoarthritis
Total Total of all reporting groups

Baseline Measures
   Group 1   Group 2   Total 
Overall Participants Analyzed 
[Units: Participants]
 13   13   26 
Age 
[Units: Participants]
     
<=18 years   0   0   0 
Between 18 and 65 years   6   5   11 
>=65 years   7   8   15 
Age 
[Units: Years]
Mean (Standard Deviation)
 65  (4.4)   67  (5.9)   66  (5.2) 
Gender 
[Units: Participants]
     
Female   2   2   4 
Male   11   11   22 
Region of Enrollment 
[Units: Participants]
     
United States   13   13   26 


  Outcome Measures

1.  Primary:   Gait Velocity   [ Time Frame: Baseline ]

2.  Secondary:   Gait Velocity With a Cane in Hip OA Subjects   [ Time Frame: Baseline ]

3.  Secondary:   Gait Velocity   [ Time Frame: 4 weeks ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Results Point of Contact:  
Name/Title: Meika A. Fang, MD
Organization: Arthritis Foundation
phone: 310-478-3711 ext 84503
e-mail: meika.fang@va.gov



Responsible Party: Meika A. Fang, MD, Arthritis Foundation
ClinicalTrials.gov Identifier: NCT00506714     History of Changes
Other Study ID Numbers: 2007-030430
First Submitted: July 20, 2007
First Posted: July 25, 2007
Results First Submitted: February 6, 2012
Results First Posted: September 28, 2012
Last Update Posted: October 4, 2012